Search | Page 13 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... to intrathecal chemotherapy . Prior allogeneic or autologous hematopoietic stem cell transplant in the last 6 months. Patients who are taking ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.

  2. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... of chemotherapy and radiation before giving the stem cells . However, high doses of chemotherapy and radiation can have ... within the preceding 12 months. One prior allogeneic stem cell transplant within the preceding 24 months. Prior ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  3. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... to intrathecal chemotherapy . Prior allogeneic or autologous hematopoietic stem cell transplant in the last 6 months. Patients who are taking ...

    Clinical Trial last updated 06/03/2016 - 2:54pm.

  4. Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant

    ... hematologic malignancies undergoing donor peripheral blood stem cell (PBSC) transplant. Giving chemotherapy and total-body ... Intervention:  Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Undergo allogeneic ...

    Clinical Trial last updated 04/28/2016 - 12:07pm.

  5. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... GVHD is one of the most common complications of a stem cell transplant . Status:  ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  6. Allogenic stem cell transplantation for older patients with AML and MDS

    ... or acute myeloid leukemia (AML). For these patients, allogeneic stem cell transplantation is the only treatment that has demonstrated the ...

    Research Review last updated 05/02/2016 - 9:31am.

  7. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... treatment; patients who have received prior autologous or allogeneic stem cell transplantation are not eligible; patients may have received 1 or 2 ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  8. Total Marrow Irradiation for Refractory Acute Leukemia

    ... before a donor umbilical cord blood or hematopoietic stem cell transplant helps stop the growth of cancer cells. It may also ... Other Names: umbilical cord blood allogeneic hematopoietic stem cell transplantation Biological: Granulocyte ...

    Clinical Trial last updated 05/02/2016 - 9:22am.

  9. Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

    ... the patient's immune system from rejecting the donor's stem cells . When the healthy stem cells from an unrelated donor , ... Intervention:  Procedure: Allogeneic Hematopoietic Stem Cell Transplantation Undergo umbilical cord ...

    Clinical Trial last updated 04/28/2016 - 1:52pm.

  10. Cord Blood Transplant

    ... Purpose:  Allogeneic hematopoietic cell transplantation (allo- HCT) is a curative therapy ... donor is the most commonly used source of allogeneic stem cells . However, HLA matched siblings are available for less than one ...

    Clinical Trial last updated 04/27/2016 - 9:59am.